PGR and breast cancer: In fact, the methylation status of RPRM CGIs was associated with some clinicopathological features in breast cancer patients, such as age (p < 0.05), ERα status (p < 0.0001), PR status (p < 0.05) and molecular subtypes (p < 0.001) (Table 1).